Macrae Sandy - Insider Non-Derivative Transactions at SANGAMO THERAPEUTICS, INC (SGMO) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Aug 25, 2024, Macrae Sandy's relationship to SANGAMO THERAPEUTICS, INC (SGMO) is Director,Officer (PRESIDENT, CEO AND DIRECTOR), and currently has 2,526,698 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SGMO insiders.

Data Source: SEC.
Macrae Sandy - Insider Non-Derivative Transactions of SGMO Common Stock
Macrae Sandy - Insider Non-Derivative Transactions at SGMO
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Aug 26, 2024 F -- (Common Stock) 7492 0.86 2526698
Aug 25, 2024 F -- (Common Stock) 5261 0.86 2534190
May 26, 2024 F -- (Common Stock) 7492 0.6 2539451
May 25, 2024 F -- (Common Stock) 5261 0.6 2546943
Feb 26, 2024 F -- (Common Stock) 24157 1.13 2552204
Feb 25, 2024 F -- (Common Stock) 16115 1.13 2576361
Jan 23, 2024 Acquisition -- (Common Stock) 2000000 0 2592476
Nov 26, 2023 F -- (Common Stock) 10411 0.38 592476
Aug 26, 2023 F -- (Common Stock) 10411 0.77 602887
May 26, 2023 F -- (Common Stock) 10411 1.33 613298
Feb 26, 2023 F -- (Common Stock) 54767 2.66 623709
Feb 25, 2023 Acquisition -- (Common Stock) 157300 0 678476